Sage Journals: Discover world-class research

Abstract

Background: It has been noted that elevated inflammatory markers, such as tumor necrosis factor-α (TNF), soluble TNF receptor II (sTNF-RII), interleukin 6 (IL-6) and C-reactive protein (CRP), are characteristically found in the serum in obese patients. In this study, we examined the correlation of these markers with BMI in nonobese, obese, and morbidly obese individuals to explore this relationship across the broad range of obesity. Methods: A total of 9 nonobese, including normal and overweight (body mass index [BMI] <30 kg/m²) and 41 obese (BMI≥ 30 kg/m²) adults were included in this study. Among obese subjects, 11 subjects were grade I or II obese (BMI ≥30 and <40 kg/m²), and 30 subjects were morbidly obese (grade III obese, BMI≥ 40 kg/m²). Serum levels of glucose, insulin, TNF, sTNF-RII, IL-6, and CRP were measured. Results: Obese subjects (BMI ≥30 kg/m²) had significantly higher serum levels of TNF, sTNF-RII, IL-6, and CRP compared with nonobese subjects. Serum levels of sTNF-RII, IL-6, and CRP, but not TNF, were positively correlated with BMI in obese subjects. However, in morbidly obese subjects, only the serum concentrations of IL-6 and CRP remained correlated with BMI, primarily because of this relationship in men. Conclusions: The present results support evidence that obesity represents an inflammatory state. In morbid obesity, the correlation of only IL-6 and CRP with BMI, particularly in males, suggests that IL-6 may be secreted in an endocrine manner in proportion to the expansion of fat mass particularly in the abdominal region, with a corresponding increase in hepatic production of CRP.

Obese subjects have high serum levels of tumor necrosis factor, interleukin 6 (IL-6) and C-reactive protein (CRP) indicating that obesity is an inflammatory state. Although IL-6 and CRP are positively correlated with body mass index in morbid obesity, this relationship only holds true in males, suggesting regional differences in fat accumulation.

Get full access to this article

View all access options for this article.

References

World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organization;1998 .

Das UN. Is obesity an inflammatory condition?Nutrition. 2001; 17:953– 966.

Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?Atherosclerosis. 2000;148:209– 214.

Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999 ;282:2131– 2135.

Bullo-Bonet M, Garcia-Lorda P, Lopez-Soriano FJ, Argiles JM, Salas-Salvado J. Tumor necrosis factor, a key role in obesity? FEBS Lett. 1999;451:215– 219.

Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationship among circulating interleukin-6, C-reactive protein and traditional cardiovascular risk factors in women. Artherioscles Thromb Vasc Biol. 2002;22:1668– 1673.

Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptor by human subcutaneous adipose tissue in vivo. Am J Physiol Endocrinol Metab. 1999 ;277:E971– E975.

Tsigos C, Kyrou I, Chala E, et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity.Metabolism. 1999;48:1332– 1335.

Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002 ;252:283– 294.

10.

Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentration in obese subjects.Circulation. 1999;99:2221– 2222.

11.

Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002 ; 288:1723– 1727.

12.

Drenick EJ, Bale GS, Seltzer F, Johnson DG. Excessive mortality and causes of death in morbidly obese men. JAMA. 1980 ;243:443– 445.

13.

Calle EE, Thum MJ, Petrelli JM, Rodriquez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097– 1105.

14.

Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man.Diabelogia. 1985;28:412– 419.

15.

Chang SA, Kim HS, Yoon KH, et al. Body mass index is the most important determining factor for degree of insulin resistance in nonobese type 2 diabetic patients in Korea. Metabolism. 2004;53 : 142–146.

16.

Bullo M, Garcia-Lorda P, Peinado-Onsurbe J, et al. TNF alpha expression of subcutaneous adipose tissue in obese and morbidly obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obes Relat Metab Disord. 2002;26:652– 658.

17.

Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995 ;95:2409– 2415.

18.

Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab. 2000 ;85:3338– 3342.

19.

Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 1995;95:2111– 2119.

20.

Eurlings PM, Van Der Kallen CJ, Geurts JM, Flavell DM, de Bruin TW. Identification of differentially expressed genes in subcutaneous adipose tissue from subjects with familial combined hyerlipidemia. J Lipid Res. 2002;43:930– 935.

21.

Schroder J, Stuber F, Gallati H, Schade FU, Kremer B. Pattern of soluble TNF receptor I, and II in sepsis. Infection. 1995 ;22:143– 148.

22.

Senn JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem. 2003;278 :13740– 13746.

23.

Kern PA, Rauganathan S, Li C, Schade FU, Kremer B. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001 ;280:E745– E751.

24.

Hube F, Birgel M, Lee YM, Hauner H. Expression pattern of tumor necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin dependent diabetes mellitus. Eur J Clin Invest. 1999;29:672– 678.

25.

Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot differences and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998 ;83:847– 850.

26.

Vague J. The degree of masculine differentiation of obesity, a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculus disease. Am J Clin Nutr. 1956 ;4:20– 38.

27.

Bjorntorp P. Metabolic implications of body fat distribution.Diabetes Care. 1991;14:1132– 1143.

28.

Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003 ; 107:363– 369.

29.

Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995 ;333:677– 685.

30.

Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004 ;14:589– 600.

31.

Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23:1042– 1047.

Serum Levels of Interleukin-6 and C-Reactive Protein Correlate With Body Mass Index Across the Broad Range of Obesity

Abstract

Get full access to this article

References